Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder Neoplasms | 5 | 2013 | 138 | 1.020 |
Why?
|
| Common Cold | 1 | 2022 | 8 | 0.860 |
Why?
|
| Muromegalovirus | 3 | 2011 | 4 | 0.700 |
Why?
|
| Herpesviridae Infections | 2 | 2009 | 23 | 0.600 |
Why?
|
| Gene Transfer Techniques | 2 | 2013 | 173 | 0.540 |
Why?
|
| Virus Replication | 2 | 2010 | 104 | 0.540 |
Why?
|
| Genetic Therapy | 3 | 2013 | 291 | 0.520 |
Why?
|
| Urinary Catheterization | 1 | 2013 | 27 | 0.460 |
Why?
|
| Escherichia coli | 2 | 2005 | 368 | 0.400 |
Why?
|
| Transduction, Genetic | 2 | 2011 | 81 | 0.370 |
Why?
|
| Viral Interference | 1 | 2010 | 1 | 0.360 |
Why?
|
| Virus Physiological Phenomena | 1 | 2010 | 1 | 0.360 |
Why?
|
| Helper Viruses | 1 | 2010 | 2 | 0.360 |
Why?
|
| Viruses | 1 | 2010 | 14 | 0.360 |
Why?
|
| Adenoviruses, Human | 1 | 2009 | 12 | 0.350 |
Why?
|
| Hepatitis, Viral, Animal | 1 | 2009 | 1 | 0.350 |
Why?
|
| Receptors, Virus | 1 | 2009 | 20 | 0.350 |
Why?
|
| Xerostomia | 1 | 2009 | 24 | 0.340 |
Why?
|
| Adenoviridae | 3 | 2013 | 295 | 0.310 |
Why?
|
| Keratitis, Herpetic | 1 | 2006 | 2 | 0.290 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2006 | 72 | 0.280 |
Why?
|
| Genes, Immunoglobulin | 1 | 2006 | 56 | 0.280 |
Why?
|
| Coliphages | 1 | 2005 | 6 | 0.260 |
Why?
|
| CD13 Antigens | 1 | 2005 | 5 | 0.260 |
Why?
|
| Intestinal Mucosa | 1 | 2005 | 219 | 0.230 |
Why?
|
| Vaccines, Attenuated | 1 | 2022 | 10 | 0.220 |
Why?
|
| Rhinovirus | 1 | 2022 | 15 | 0.220 |
Why?
|
| Bacteriophage P1 | 1 | 2002 | 10 | 0.210 |
Why?
|
| Genetic Vectors | 3 | 2013 | 311 | 0.210 |
Why?
|
| Bacteriophage M13 | 1 | 2002 | 12 | 0.210 |
Why?
|
| Mice | 9 | 2013 | 8474 | 0.210 |
Why?
|
| Animals | 10 | 2022 | 20880 | 0.210 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 3 | 2009 | 65 | 0.190 |
Why?
|
| Polymers | 2 | 2013 | 244 | 0.170 |
Why?
|
| Pandemics | 1 | 2022 | 349 | 0.160 |
Why?
|
| Luciferases | 2 | 2013 | 105 | 0.140 |
Why?
|
| Mice, Inbred ICR | 3 | 2005 | 44 | 0.140 |
Why?
|
| Transgenes | 2 | 2013 | 92 | 0.140 |
Why?
|
| Disease Models, Animal | 3 | 2009 | 2550 | 0.130 |
Why?
|
| Cytomegalovirus Infections | 2 | 2007 | 69 | 0.130 |
Why?
|
| Cell Line, Tumor | 5 | 2013 | 1851 | 0.130 |
Why?
|
| Luminescent Measurements | 1 | 2013 | 58 | 0.110 |
Why?
|
| Aminoglycosides | 1 | 2013 | 54 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 2 | 2013 | 200 | 0.110 |
Why?
|
| Mice, Knockout | 2 | 2009 | 1692 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 532 | 0.100 |
Why?
|
| Female | 8 | 2013 | 38021 | 0.100 |
Why?
|
| Germinal Center | 1 | 2011 | 13 | 0.100 |
Why?
|
| Gene Expression | 2 | 2013 | 770 | 0.100 |
Why?
|
| Salivary Glands | 1 | 2011 | 52 | 0.090 |
Why?
|
| Epoxy Resins | 1 | 2009 | 4 | 0.090 |
Why?
|
| Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 2009 | 3 | 0.090 |
Why?
|
| Aquaporin 5 | 1 | 2009 | 1 | 0.090 |
Why?
|
| Salivation | 1 | 2009 | 7 | 0.090 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 166 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 306 | 0.080 |
Why?
|
| Humans | 8 | 2022 | 68549 | 0.080 |
Why?
|
| Cell Death | 1 | 2009 | 329 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2005 | 2791 | 0.080 |
Why?
|
| Peptide Elongation Factor 2 | 1 | 2007 | 14 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 742 | 0.070 |
Why?
|
| Salivary Gland Diseases | 1 | 2007 | 3 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2009 | 332 | 0.070 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2006 | 44 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 1040 | 0.070 |
Why?
|
| Corneal Stroma | 1 | 2006 | 20 | 0.070 |
Why?
|
| Gene Frequency | 1 | 2006 | 207 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2007 | 231 | 0.070 |
Why?
|
| Lysogeny | 1 | 2005 | 4 | 0.060 |
Why?
|
| Phenanthrolines | 1 | 2005 | 5 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 492 | 0.060 |
Why?
|
| Neutralization Tests | 1 | 2005 | 19 | 0.060 |
Why?
|
| Edetic Acid | 1 | 2005 | 29 | 0.060 |
Why?
|
| Apoptosis | 2 | 2009 | 1641 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2009 | 718 | 0.060 |
Why?
|
| Mice, Inbred CBA | 1 | 2005 | 107 | 0.060 |
Why?
|
| Male | 4 | 2013 | 37283 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2005 | 76 | 0.060 |
Why?
|
| Feces | 1 | 2005 | 88 | 0.060 |
Why?
|
| Species Specificity | 1 | 2005 | 302 | 0.060 |
Why?
|
| Mice, Nude | 1 | 2005 | 294 | 0.060 |
Why?
|
| Genotype | 1 | 2006 | 785 | 0.060 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 481 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 765 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2005 | 524 | 0.060 |
Why?
|
| Bacteriophages | 1 | 2003 | 24 | 0.060 |
Why?
|
| Bacterial Toxins | 1 | 2003 | 50 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 786 | 0.050 |
Why?
|
| Escherichia coli Proteins | 1 | 2003 | 64 | 0.050 |
Why?
|
| Mathematical Computing | 1 | 2002 | 12 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2005 | 434 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 248 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 1070 | 0.050 |
Why?
|
| Bacterial Infections | 1 | 2003 | 163 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 778 | 0.050 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 2 | 2009 | 18 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2003 | 617 | 0.040 |
Why?
|
| Models, Biological | 1 | 2002 | 981 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 507 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 4843 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 1174 | 0.030 |
Why?
|
| Child | 1 | 2006 | 6401 | 0.030 |
Why?
|
| Adolescent | 1 | 2006 | 8904 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2011 | 40 | 0.020 |
Why?
|
| Urine | 1 | 2011 | 47 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 100 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 191 | 0.020 |
Why?
|
| Aged | 1 | 2006 | 14842 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2011 | 110 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2011 | 228 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 489 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 710 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 614 | 0.020 |
Why?
|
| Middle Aged | 1 | 2006 | 21119 | 0.020 |
Why?
|
| Adult | 1 | 2006 | 21379 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2009 | 447 | 0.020 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2007 | 17 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2007 | 32 | 0.020 |
Why?
|
| Free Radicals | 1 | 2007 | 65 | 0.020 |
Why?
|
| Iron Chelating Agents | 1 | 2007 | 31 | 0.020 |
Why?
|
| Deferoxamine | 1 | 2007 | 45 | 0.020 |
Why?
|
| Viremia | 1 | 2007 | 13 | 0.020 |
Why?
|
| Splenic Diseases | 1 | 2007 | 10 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 756 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2007 | 260 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 168 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2007 | 181 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 2007 | 63 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1174 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2007 | 312 | 0.020 |
Why?
|
| Liver Diseases | 1 | 2007 | 193 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2007 | 1200 | 0.010 |
Why?
|
| Phenotype | 1 | 2007 | 946 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2003 | 41 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 258 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2009 | 2689 | 0.010 |
Why?
|